Valued Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$116K Buy
795
+58
+8% +$8.02K 0.04% 67
2026
Q2
$95.3K Buy
737
+22
+3% +$2.58K 0.03% 74
2026
Q1
$86.6K Buy
715
+271
+61% +$31.3K 0.04% 71
2025
Q4
$47.2K Buy
444
+94
+27% +$8.82K 0.02% 95
2025
Q3
$29.7K Buy
350
+18
+5% +$1.48K 0.01% 120
2025
Q2
$26.5K Sell
332
-38
-10% -$3.02K 0.01% 129
2025
Q1
$33.5K Sell
370
-52
-12% -$4.86K 0.02% 116
2024
Q4
$42.3K Buy
422
+11
+3% +$1.13K 0.03% 98
2024
Q3
$47K Sell
411
-25
-6% -$2.97K 0.03% 83
2024
Q2
$54.2K Buy
436
+210
+93% +$27K 0.04% 68
2024
Q1
$30K Sell
226
-181
-44% -$22.3K 0.02% 94
2023
Q4
$42.1K Buy
+407
New +$42.2K 0.04% 56

Other funds holding MRK

Valued Wealth Advisors's MRK Position: Q3 2026 in Review

Valued Wealth Advisors increased its Merck (MRK) stake by 7.9% in Q3 2026, buying an estimated $8.02K and bringing the position to 795 shares worth $116K. The position accounts for 0.04% of the portfolio, ranked #67.

Valued Wealth Advisors first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. 2,434 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Valued Wealth Advisors held 795 shares of Merck worth $116K as of Q3 2026.
  • Valued Wealth Advisors bought 58 Merck shares in Q3 2026, an estimated $8.02K.
  • Merck made up 0.04% of Valued Wealth Advisors's portfolio in Q3 2026, its #67 holding.
  • Valued Wealth Advisors first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • 2,434 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Valued Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.